Documents

February 2012

• GOP Doctors Caucus Urges SGR Repeal, But Avoids War Funding Issue
• U.S. Files Supreme Court Brief On ACA's Medicaid Expansion
• Administration Releases New Final Rule On Coverage Of Preventive Services
• NACDS Urges CMS To Cease Publication Of FUL Lists Until Final AMP Rule Issued
• Reactions To President's No-Cost Birth Control Compromise
• President's Remarks On Shift On Contraception Issue
• FDA Issues Heparin Guidance
• Kohl, Grassley, Blumenthal Urge Release Of Delayed Medical Device Rule
• Reactions To Summary Of Benefits Rule
• CSPI Calls For FDA To Address Oyster Safety
• DeLauro Calls On FDA To Change Sugar Labeling
• Stakeholders React To Biosimilars Guidance
• FDA Issues Long-Awaited Draft Guidance Documents On Biosimilars
• Administration Unveils Final Rule On Summary Of Benefits, Coverage
• CMS Guidance Offers Parameters Of Capitated Demos For Duals
• AdvaMed Promotes Tax Reform Through Set Of Industry-Wide Principles/White Paper
• NIOSH Issues 'Lessons Learned' Report On Deepwater Horizon
• Schwartz, Cassidy: Progress On Quality-Based Payment System Hinges On SGR Repeal
• District Court Rules That FDA Acted Within Authority When Requiring Studies To Support Approval Of Generic Lovenox
• PhRMA Elects Three New Members To Board Of Directors
• Consumer Groups Petition FDA To Ban GE Salmon As An Unsafe Food Additive
• Senate Finance Republicans Take HHS To Task For Touting 'Free' ACA Benefits
• Stronger Medical Device Oversight Urged By Patient Safety Activists
• Rand Study: Financial Burden Of Prescription Drugs Is Dropping
• Boustany, Coburn Request Information On Financial Mismanagement At HHS